We demonstrated the importance of targeting multiple key genes of the KRAS network by RNA interference using MIR143#12 because the majority of KRAS mutant cancers have the KRAS recruitment system, the so-called positive circuit, as a survival system and activate it when insufficient suppressive signals enter key pathways involving KRAS, AKT, and MAPK. The gene discussed is AKT1; the disease is cancer.